-- 
Almirall Sells Lung Anti-Inflammatory Drug Roflumilast in Spain

-- B y   M a n u e l   B a i g o r r i
-- 
2011-10-03T06:32:57Z

-- http://www.bloomberg.com/news/2011-10-03/almirall-sells-lung-anti-inflammatory-drug-roflumilast-in-spain.html
Almirall SA (ALM)  has started marketing its
anti-inflammatory oral treatment Roflumilast in  Spain , licensed
by Nycomed, for patients with chronic lung diseases, the company
said in a regulatory filing today.  To contact the editor responsible for this story:
Manuel Baigorri at 
 mbaigorri@bloomberg.net  